Clinical Trial Update: Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fenretinide in patients with advanced or metastatic hormone-refractory prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: Cancer Therapeutics Research Group | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED